Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: JEB who wrote (6545)	12/23/1998 9:50:00 PM
From: BigKNY3	Read Replies (2) \| Respond to of 9523

PeabodyCam Click here to see an actual videotape of Mr. Peabody reacting to today's PFE close. marimba.com Here's the scoop: - PFE ended the day at an all-time high close of 120.38 representing a 61.4% YTD increase. -The Big Pharma Index reached an all-time high of 80.23, a 46.4% YTD increase. -Watch out for Thursday's morning action, PFE is taking aim at its all-time high of 121.75. Thank you, Santa!! PFE - PFIZER INC Last Price: 120 3/8 at 17:01 (modest sell-off from 4:00 high) Change: Up 3 3/16 (+2.72%) High: 120 13/16 at 15:59 Low: 117 3/4 at 9:52 Open: 118 1/8 Previous Close: 117 3/16 on 12/22 Volume: 3,427,600 (strong volume) 30-Day Avg. Volume: 2,705,000 Shares Outstanding: 1,297,794,000 52-Week High: 121 3/4 (Thursday's target!) 52-Week Low: 70.37 Beta: 1.01 Yield: 0.70% P/E Ratio: 48.3 EPS: 2.49 Have PFun during the holidays!! BigKNY3 PS: Anthony, thanks for the great Pharma links. I wish you and your family a very happy and pfunfilled holiday!

To: JEB who wrote (6545)	1/4/1999 3:33:00 AM
From: Anthony Wong	Read Replies (2) \| Respond to of 9523

CELEBREX(TM) MEDIA TELECONFERENCE ADVISORY [on Jan 4, 10 A.M] PR Wire January 3, 1999, 7:33 p.m. ET Celebrex(TM) Approved by Food and Drug Administration Executives from Skokie-based G.D. Searle & Co. and New York-based Pfizer, Inc. -- co-promoters of Celebrex(TM) (celecoxib) -- along with investigators and patients, will discuss a new medication approved for the relief of the signs and symptoms of osteoarthritis, and rheumatoid arthritis in adults. On January 4th at 10:00 A.M. (CST), experts will participate in a teleconference (to participate, dial in to 1-888-538-9956) to answer questions and provide an overview of: -- Celebrex clinical data -- The science behind COX-2 inhibition -- Celebrex pricing -- Economic impact of arthritis -- Patient and physician experiences Callers will be able to participate in Q&A following the presentation. For the first time, St. Louis-area Celebrex clinical investigators and patients will be available for interviews after the teleconference. CONTACT: Lori Fisher of Monsanto, 314-694-8535; or Maureen Suda of Chandler Chicco Agency, 212-229-8448. SOURCE G.D. Searle & Co. -0- 01/03/99 /PRNewswire -- Jan. 03/ (PFE) CO: G.D. Searle & Co.; Pfizer, Inc.; Monsanto ST: New York, Missouri IN: MTC HEA SU: PDT -0- Jan/03/1999 19:18 EOS (PRN) Jan/03/99 19:18 86 -0- (PRN) Jan/03/1999 19:33 More News: PFE